BB BIOTECH AG (BBAGF.PK) released earnings for its full year that Increased, from the same period last year
The company's earnings totaled CHF578.13 million, or CHF10.54 per share. This compares with CHF75.90 million, or CHF1.38 per share, last year.
The company's revenue for the period rose 448.8% to CHF616.74 million from CHF112.37 million last year.
BB BIOTECH AG earnings at a glance (GAAP) :
-Earnings: CHF578.13 Mln. vs. CHF75.90 Mln. last year.-EPS: CHF10.54 vs. CHF1.38 last year.-Revenue: CHF616.74 Mln vs. CHF112.37 Mln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.